Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.
Authors:
- C D BucknerCBC D Buckner
- R BriggsRBR Briggs
- R A CliftRCR A Clift
- A FeferAFA Fefer
- D D FunkDFD D Funk
- H GlucksbergHGH Glucksberg
- P E NeimanPNP E Neiman
- R StorbRSR Storb
- E D ThomasETE D Thomas